For this analysis, we compare the results from SpliceMutr in the breast cancer (BRCA, 1,094 samples) TCGA cohort per sample, in which the number of validated IEAtlas kmers found to be MHC-binding kmers is determined by the HLA genotype per sample. This evidence concerns the gene HLA-C and breast cancer.